Literature DB >> 12486127

Manipulation of EphB2 regulatory motifs and SH2 binding sites switches MAPK signaling and biological activity.

Jiefei Tong1, Sabine Elowe, Piers Nash, Tony Pawson.   

Abstract

Signaling by the Eph family of receptor tyrosine kinases (RTKs) is complex, because they can interact with a variety of intracellular targets, and can potentially induce distinct responses in different cell types. In NG108 neuronal cells, activated EphB2 recruits p120RasGAP, in a fashion that is associated with down-regulation of the Ras-Erk mitogen-activated kinase (MAPK) pathway and neurite retraction. To pursue the role of the Ras-MAPK pathway in EphB2-mediated growth cone collapse, and to explore the biochemical and biological functions of Eph receptors, we sought to re-engineer the signaling properties of EphB2 by manipulating its regulatory motifs and SH2 binding sites. An EphB2 mutant that retained juxtamembrane (JM) RasGAP binding sites but incorporated a Grb2 binding motif at an alternate RasGAP binding site within the kinase domain had little effect on basal Erk MAPK activation. In contrast, elimination of all RasGAP binding sites, accompanied by the addition of a Grb2 binding site within the kinase domain, led to an increase in phospho-Erk levels in NG108 cells following ephrin-B1 stimulation. Functional assays indicated a correlation between neurite retraction and the ability of the EphB2 mutants to down-regulate Ras-Erk MAPK signaling. These data suggest that EphB2 can be designed to repress, stabilize, or activate the Ras-Erk MAPK pathway by the manipulation of RasGAP and Grb2 SH2 domain binding sites and support the notion that Erk MAPK regulation plays a significant role in axon guidance. The behavior of EphB2 variants with mutations in the JM region and kinase domains suggests an intricate pattern of regulation and target recognition by Eph receptors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12486127     DOI: 10.1074/jbc.M208972200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Rho GTPases regulate PTPmu-mediated nasal neurite outgrowth and temporal repulsion of retinal ganglion cell neurons.

Authors:  Denice L Major; Susann M Brady-Kalnay
Journal:  Mol Cell Neurosci       Date:  2007-01-17       Impact factor: 4.314

2.  Quantitative phosphotyrosine proteomics of EphB2 signaling by stable isotope labeling with amino acids in cell culture (SILAC).

Authors:  Guoan Zhang; Daniel S Spellman; Edward Y Skolnik; Thomas A Neubert
Journal:  J Proteome Res       Date:  2006-03       Impact factor: 4.466

Review 3.  Therapeutic targeting of EPH receptors and their ligands.

Authors:  Andrew W Boyd; Perry F Bartlett; Martin Lackmann
Journal:  Nat Rev Drug Discov       Date:  2014-01       Impact factor: 84.694

Review 4.  Eph-dependent cell-cell adhesion and segregation in development and cancer.

Authors:  Eva Nievergall; Martin Lackmann; Peter W Janes
Journal:  Cell Mol Life Sci       Date:  2011-12-28       Impact factor: 9.261

5.  EphA activation overrides the presynaptic actions of BDNF.

Authors:  Caixia Bi; Xin Yue; Renping Zhou; Mark R Plummer
Journal:  J Neurophysiol       Date:  2011-03-16       Impact factor: 2.714

Review 6.  EphA receptor signaling--complexity and emerging themes.

Authors:  Hui Miao; Bingcheng Wang
Journal:  Semin Cell Dev Biol       Date:  2011-10-21       Impact factor: 7.727

7.  Soluble ephrin-B2 mediates apoptosis in retinal neovascularization and in endothelial cells.

Authors:  Michael H Davies; David O Zamora; Justine R Smith; Michael R Powers
Journal:  Microvasc Res       Date:  2009-02-13       Impact factor: 3.514

8.  Screening for EphB signaling effectors using SILAC with a linear ion trap-orbitrap mass spectrometer.

Authors:  Guoan Zhang; David Fenyö; Thomas A Neubert
Journal:  J Proteome Res       Date:  2008-09-25       Impact factor: 4.466

9.  A subset of signal transduction pathways is required for hippocampal growth cone collapse induced by ephrin-A5.

Authors:  Xin Yue; Cheryl Dreyfus; Tony Ah-Ng Kong; Renping Zhou
Journal:  Dev Neurobiol       Date:  2008-09-01       Impact factor: 3.964

10.  Targeted mutation of EphB1 receptor prevents development of neuropathic hyperalgesia and physical dependence on morphine in mice.

Authors:  Yuan Han; Xue-Song Song; Wen-Tao Liu; Mark Henkemeyer; Xue-Jun Song
Journal:  Mol Pain       Date:  2008-11-21       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.